2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: a Position Paper of the International Lipid Expert Panel (ILEP)

dc.contributor.authorBanach, Maciej
dc.contributor.authorReiner, Željko
dc.contributor.authorSurma, Stanisaw
dc.contributor.authorBajraktari, Gani
dc.contributor.authorBielecka-Dabrowa, Agata
dc.contributor.authorBunc, Matjaz
dc.contributor.authorBytyci, Ibadete
dc.contributor.authorCeska, Richard
dc.contributor.authorCicero, Arrigo F. G.
dc.contributor.authorDudek, Darius
dc.contributor.authorDyrbus, Krzysztof
dc.contributor.authorFedacko, Jan
dc.contributor.authorFras, Zlatko
dc.contributor.authorGaita, Dan
dc.contributor.authorGavish, Dov
dc.contributor.authorGierlotka, Marek
dc.contributor.authorGil, Robert
dc.contributor.authorGouni-Berthold, Ioanna
dc.contributor.authorJankowski, Piotr
dc.contributor.authorJárai, Zoltán
dc.contributor.authorJózwiak, Jacek
dc.contributor.authorKatsiki, Niki
dc.contributor.authorLatkovskis, Gustavs
dc.contributor.authorMagda, Stefania Lucia
dc.contributor.authorMargetic, Eduard
dc.contributor.authorMargoczy, Roman
dc.contributor.authorMitchenko, Olena
dc.contributor.authorDurak-Nalbantic, Azra
dc.contributor.authorOstadal, Petr
dc.contributor.authorParagh, György
dc.contributor.authorPetrulioniene, Zaneta
dc.contributor.authorPaneni, Francesco
dc.contributor.authorPećin, Ivan
dc.contributor.authorPella, Daniel
dc.contributor.authorPostadzhiyan, Arman
dc.contributor.authorStoian, Anca Pantea
dc.contributor.authorTrbusic, Matias
dc.contributor.authorUdroiu, Cristian Alexandru
dc.contributor.authorViigimaa, Margus
dc.contributor.authorVinereanu, Dragos
dc.contributor.authorVlachopoulos, Charalambos
dc.contributor.authorVrablík, Michal
dc.contributor.authorVulic, Dusko
dc.contributor.authorPenson, Peter E.
dc.date.accessioned2025-02-14T10:28:25Z
dc.date.available2025-02-14T10:28:25Z
dc.date.issued2024
dc.date.oa2025-06-19
dc.date.pasync2025-04-30T23:08:49Z
dc.date.updated2025-02-14T10:28:25Z
dc.description.correctorkzs
dc.identifier.citationDrugs. -84 : 12 (2024), p. 1541-1577. -Drugs. - 0012-6667
dc.identifier.doihttp://dx.doi.org/10.1007/s40265-024-02105-5
dc.identifier.issn0012-6667
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM127831
dc.identifier.scopus85208142733
dc.identifier.urihttps://hdl.handle.net/2437/387046
dc.identifier.urlhttps://link.springer.com/10.1007/s40265-024-02105-5
dc.identifier.wos001348488500001
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.title2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: a Position Paper of the International Lipid Expert Panel (ILEP)
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_s40265-024-02105-5.pdf
Méret:
4.11 MB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat